Related Experiment Video
Updated: Jan 25, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Cancer drug resistance: A fleet to conquer
Showket Hussain1, Ankita Singh1, Sheeraz Un Nazir1
1Division of Cellular and Molecular Diagnostics, National Institute of Cancer Prevention and Research, Noida, India.
Abstract:
Cancer is a disease that claims millions of lives each year across the world. Despite advancement in technologies and therapeutics for treating the disease, these modes are often found to turn ineffective during the course of treatment. The resistance against drugs in cancer patients stems from multiple factors, which constitute genetic heterogeneity like gene mutations, tumor microenvironment, exosomes, miRNAs, high rate of drug efflux from cells, and so on. This review attempts to collate all such known and reported factors that influence cancer drug resistance and may help researchers with information that might be useful in developing better therapeutics in near future to enable better management of several cancers across the world.
Insights
Cancer drug resistance is a major challenge, often caused by genetic factors and the tumor environment. Understanding these causes is key to developing more effective cancer treatments and improving patient outcomes worldwide.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer remains a leading cause of global mortality.
- Current cancer therapeutics frequently encounter treatment failure due to drug resistance.
- Identifying the mechanisms of drug resistance is crucial for advancing cancer care.
Purpose of the Study:
- To review and consolidate known factors contributing to cancer drug resistance.
- To provide researchers with comprehensive information on resistance mechanisms.
- To aid in the development of novel and effective cancer therapeutics.
Main Methods:
- Literature review of scientific publications.
- Compilation of reported factors influencing cancer drug resistance.
- Analysis of genetic and non-genetic resistance mechanisms.
Main Results:
- Cancer drug resistance is multifactorial, involving genetic heterogeneity (e.g., gene mutations).
- Key contributors include the tumor microenvironment, exosomes, and microRNAs (miRNAs).
- High rates of drug efflux from cancer cells also play a significant role.
Conclusions:
- A thorough understanding of cancer drug resistance factors is essential.
- This knowledge can guide the development of next-generation cancer therapies.
- Improved therapeutics will enhance the management of various cancer types globally.
More Related Videos
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...